MyPEEPS Mobile for HIV Prevention
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment MyPEEPS Mobile for HIV Prevention?
How is the MyPEEPS Mobile treatment different from other HIV prevention treatments?
MyPEEPS Mobile is unique because it delivers HIV prevention information through a mobile app specifically designed for young men, making it accessible and engaging for a diverse group of young men who have sex with men. Unlike traditional face-to-face interventions, this app provides a personalized and private way to learn about HIV prevention, tailored to the needs and preferences of young users.14567
What is the purpose of this trial?
This study will use community-informed advertisements and messages through electronic methods to recruit and retain a large (N=2,500), diverse national sample of high-risk young men who have sex with men (YMSM) and non-binary individuals that are assigned male sex at birth, 16-29 years of age to determine the efficacy of the MyPEEPS Mobile intervention on reduced incident HIV infections in comparison to a standard of care condition and to examine the degree to which reduced incident HIV infections occurs in the context of potential multilevel moderators and conceptual mediators. This is key to advancing HIV prevention among HIV-negative US persons at extremely high-risk for HIV seroconversion.
Research Team
Rebecca Schnall, PhD, MPH
Principal Investigator
Columbia University
Robert Garofalo, MD, MPH
Principal Investigator
Ann & Robert H Lurie Children's Hospital of Chicago
Dustin Duncan, ScD
Principal Investigator
Columbia University
Eligibility Criteria
The MyPEEPS LITE Trial is for young men and non-binary individuals assigned male at birth, aged 16-29, who are at high risk for HIV. Participants should be sexually active with other men and can have either a suppressed or unsuppressed HIV status.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants randomized to the intervention arm will have access to MyPEEPS Mobile for 6 months, a secure web app with content delivered through games, scenarios, and role-plays within 22 mobile activities.
Control
Participants randomized to the control arm will receive standard of care, including HIV home testing every 6 months, information on sexual behaviors, and referrals for PrEP and STD testing.
Follow-up
Participants are monitored for HIV incidence and sexual risk behaviors at 6 and 12 months using OraQuick In-Home HIV Tests and the AIDS-Risk Behavior Assessment.
Treatment Details
Interventions
- MyPEEPS Mobile
MyPEEPS Mobile is already approved in United States for the following indications:
- HIV prevention in young men who have sex with men (YMSM)
- HIV prevention in young transgender men and transmasculine youth
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Collaborator
Northwestern University
Collaborator
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator